Literature DB >> 3933204

Quantification of haemagglutinin of influenza Tween-ether split vaccines by immunodiffusion.

R Johannsen, H Moser, J Hinz, H J Friesen, H Gruschkau.   

Abstract

The haemagglutinin content of monovalent influenza whole virus and Tween-ether split vaccines derived therefrom, were assayed comparatively using single radial immunodiffusion (SRID, the only test recommended for influenza vaccines by the European Pharmacopoeia Commission), quantitative SDS-polyacrylamide gel electrophoresis and immunization of guinea pigs. If SRID was performed with split vaccines, reduced haemagglutinin values were consistently recorded which were 50-25% of values obtained before disruption of virions. If, however, disruption was conducted in the presence of excess detergent thus preventing aggregate formation of solubilized haemagglutinin, test values comparable to those of whole virus vaccines were obtained. In agreement with these results, immunization experiments revealed that whole virus and the corresponding split vaccines exhibited comparable immunogenicity in guinea pigs. From SDS-polyacrylamide gel electrophoresis and densitometer tracings obtained by scanning the gels after staining with either Coomassie Blue or fluorescein isothiocyanate-labelled concanavalin A it was calculated that about 90% of whole virus HA2 was recovered in Tween-ether split vaccines. From our experiments we conclude that precise quantification of solubilized haemagglutinin is not achievable by the single radial immunodiffusion test alone. Aggregate formation of solubilized haemagglutinin frequently occurs when the applied detergent is removed and, therefore, a physico-chemical method including an effective disaggregation procedure like SDS treatment in combination with PAGE is recommended.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3933204     DOI: 10.1016/0264-410x(85)90114-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Intranasal immunization of mice with influenza vaccine in combination with the adjuvant LT-R72 induces potent mucosal and serum immunity which is stronger than that with traditional intramuscular immunization.

Authors:  J D Barackman; G Ott; D T O'Hagan
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

2.  Oral administration of influenza vaccine in combination with the adjuvants LT-K63 and LT-R72 induces potent immune responses comparable to or stronger than traditional intramuscular immunization.

Authors:  J D Barackman; G Ott; S Pine; D T O'Hagan
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

3.  Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes.

Authors:  Theone C Kon; Adrian Onu; Laurentiu Berbecila; Emilia Lupulescu; Alina Ghiorgisor; Gideon F Kersten; Yi-Qing Cui; Jean-Pierre Amorij; Leo Van der Pol
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

4.  Development and characterization of standard reagents for cell-based prepandemic influenza vaccine products.

Authors:  Chia-Chun Lai; Tsai-Chuan Weng; Po-Ling Chen; Yu-Fen Tseng; Chun-Yang Lin; Min-Yuan Chia; Wang-Chou Sung; Min-Shi Lee; Alan Yung-Chih Hu
Journal:  Hum Vaccin Immunother       Date:  2020-03-02       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.